Arora et al., 2016 - Google Patents
An update on polysaccharide-based nanomaterials for antimicrobial applicationsArora et al., 2016
- Document ID
- 7456911615006186886
- Author
- Arora D
- Sharma N
- Sharma V
- Abrol V
- Shankar R
- Jaglan S
- Publication year
- Publication venue
- Applied microbiology and biotechnology
External Links
Snippet
Scientific community has made a lot of efforts to combat the infectious diseases using antimicrobial agents, but these are associated with problems of development of multi-drug resistance and their adverse side effects. To tackle these challenges, nanocarrier-based …
- 230000000845 anti-microbial 0 title abstract description 57
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar, pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48876—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Arora et al. | An update on polysaccharide-based nanomaterials for antimicrobial applications | |
| Li et al. | Nanocellulose‐based antibacterial materials | |
| Javanbakht et al. | Carboxymethyl cellulose-based oral delivery systems | |
| Ahmed et al. | Chitosan & its derivatives: a review in recent innovations | |
| Anastas et al. | A review of immobilization techniques to improve the stability and bioactivity of lysozyme | |
| Alavi et al. | Antibacterial and wound healing activities of silver nanoparticles embedded in cellulose compared to other polysaccharides and protein polymers | |
| Agnihotri et al. | Development of nano-antimicrobial biomaterials for biomedical applications | |
| Jennings et al. | Chitosan Based Biomaterials Volume 1: Fundamentals | |
| Jampilek et al. | Application of nanobioformulations for controlled release and targeted biodistribution of drugs | |
| Valle Mendoza et al. | Electrospun biodegradable polymers loaded with bactericide agents | |
| Jain et al. | Dibutyrylchitin nanoparticles as novel drug carrier | |
| Beulah et al. | Green engineered chitosan nanoparticles and its biomedical applications—An overview | |
| Coma et al. | Recent advances on the development of antibacterial polysaccharide-based materials | |
| Dang et al. | Advancements in Manufacturing and Applications of Starch-Based Antimicrobial Materials | |
| Zamel et al. | Regenerated cellulose and composites for biomedical applications | |
| Yaqoob et al. | Chitosan-based nanocomposites for gene delivery: Application and future perspectives | |
| Rajivgandhi et al. | Investigation of Chitosan/Metal and Metal Oxide Nanocomposites as a New Strategy for Enhanced Anti-Biofilm Efficacy with Reduced Toxicity | |
| Singh et al. | Polysaccharide-based nanoparticles: nanocarriers for sustained delivery of drugs | |
| Vosoughi et al. | Carboxymethyl Chitosan-based Nanomaterials for Biomedical Applications: An Overview of Recent Advances and Prospects | |
| Shukla et al. | Chitosan for delivery of biomolecules | |
| Thakur | Gum based green nanocomposites and their applications | |
| Abuelella et al. | Polysaccharide based biomaterials for dermal applications | |
| Carpa et al. | Double‑network Chitosan‑based hydrogels with improved mechanical, conductive, antimicrobial, and antibiofouling properties. Gels. 2023; 9: 278 | |
| Khalid et al. | Biopolymeric-inorganic composites for drug delivery applications | |
| Bhatia | Marine polysaccharides based nano-materials and its applications |